Idifarma renews French Crédit d’impôt recherche (CIR)
Idifarma has renewed the approval by the French “Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation”, as an outsourcing partner for R&D activities for French companies under the conditions of the Crédit d’Impôt Recherche (CIR).
This research tax credit (CIR) allows French companies to obtain fiscal deductions when outsourcing their R&D activities to approved companies, like Idifarma.
France possesses a strong innovative and highly qualified scientific environment which plenty of opportunities where Idifarma can be a reliable partner. This approval shows the commitment of Idifarma to collaborate further with French companies, offering our integrated CDMO services for new drugs, with high potency capabilities and spray drying technology.
